Effect of step aerobics training with breathing exercise in asthmatic patients

Effect of step aerobics training with breathing exercise on pulmonary function, physical performance, exercise capacity, oxidative stress, airway and systemic inflammation, and quality of life in asthmatic patients

Status

Unknown

Phases

Early Phase 1

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230913002

Enrollment

Registered

2023-09-13

Start date

2023-03-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthmatic patients have stable symptoms with the ability to perform step aerobics training and breathing exercise. Asthma, Step aerobics, Inflammation

Interventions

Participants in the control group will be performed normal physical activity for 12 weeks.,Participants in the study group 1 will be performed 40 minutes step aerobics training for 12 weeks.,Participa

No Intervention Other,Experimental Other,Experimental Other

Control group,Study group 1,Study group 2

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who will be diagnosed to be moderate to severe asthma according to Global Initiative for Asthma 2. Age 18-65 years 3. Non regular exercise (less than 3 times/week and less than 30 min/day) 4. Patients will require to receive stable dose of asthma medications throughout the study.

Exclusion criteria

Exclusion criteria: 1. Other respiratory diseases such as chronic obstructive pulmonary disease, chronic respiratory failure, and respiratory infections. 2. Asthma exacerbation within 1 month 3. Congestive heart failure, chest pain from myocardial ischemia 4. Condition with musculoskeletal disorders affecting the movement of the shoulder or knee, or ankle joints. 5. Presence of orthopedic or neuromuscular conditions interfering with the ability to perform step aerobic exercise such as herniated disc, lumbar stenosis, and muscle weakness 6. Pregnancy

Design outcomes

Primary

Measure	Time frame
Airway inflammation Pre-test, Intermediate-test, and post exercise training The fractional concentration of exhaled nitric oxide by using a FeNo Vivatmo Pro,Asthma control Pre-test, Intermediate-test, and post exercise training Asthma Control Test (ACT), Asthma Quality of Life (AQLQ), and Asthma Control Questionnaire (ACQ)	—

Secondary

Measure	Time frame
Lung function Pre-test, Intermediate-test, and Post exercise training Respiratory muscle strength test, and pulmonary function test,Physical fitness Pre-test, Intermediate-test, and Post exercise training One leg stand test, Timed-up and Go test , 10- meter walk test , and Five time sit to stand test ,Exercise capacity Pre-test, Intermediate-test, and Post exercise training 6-minute walk test,Systemic inflammation Pre-test, Intermediate-test, and Post exercise training Interleukin-5 level, Blood eosinophil count, The high-sensitivity C-reactive protein (hsCRP)	—

Measure

Time frame

Lung function Pre-test, Intermediate-test, and Post exercise training Respiratory muscle strength test, and pulmonary function test,Physical fitness Pre-test, Intermediate-test, and Post exercise training One leg stand test, Timed-up and Go test , 10- meter walk test , and Five time sit to stand test ,Exercise capacity Pre-test, Intermediate-test, and Post exercise training 6-minute walk test,Systemic inflammation Pre-test, Intermediate-test, and Post exercise training Interleukin-5 level, Blood eosinophil count, The high-sensitivity C-reactive protein (hsCRP)

—

Countries

Thailand

Contacts

Public ContactNapatchanok Hanwaree

Faculty of Medicine, Khon Kaen Universtiy, Thailand

napatchanok@kkumail.com0839669554

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Apr 4, 2026